Literature DB >> 26209182

Histopathological Evidence of Lymph Node Metastasis in Papillary Thyroid Carcinoma.

Nuray Can1, Ebru Tastekin, Filiz Ozyilmaz, Yavuz Atakan Sezer, Sibel Guldiken, Necdet Sut, Nurtac Sarikas, Fulya Oz Puyan, Beril Guler, Semra Ayturk, Mehmet Celik.   

Abstract

Prophylactic lymph node dissection is still controversial due to the potentially surgery-related morbidity in management of papillary thyroid carcinomas. So, some histopathological predictors for lymph node metastasis in thyroidectomy specimens may reveal importance. The objective of this study was to define histomorphological indicators of lymph node metastasis in the patients who had been performed thyroidectomy without lymph node dissection. Clinicopathological features of patients archived in Department of Pathology at Trakya University Medical Faculty were reviewed. A total of 211 patients who had been diagnosed as papillary carcinoma and had been performed total thyroidectomy/lobectomy with central/cervical lymph node dissection were included in the study. Clinical features (age, gender, preoperative/postoperative clinical, and laboratory findings) and histopathological features (histological variant, tumor size, focality, extrathyroidal extension, tumor border, lateral tubular growth, intraglandular dissemination, stromal and lymphocytic tumor response, lymphocytic thyroiditis, lymphovascular invasion, lymph node metastasis, number of metastatic lymph nodes, extranodal extension, size of the metastatic foci) were evaluated. Male gender, conventional variant, tumor size greater than 10 mm, multifocality, extrathyroidal extension, lateral tubular growth, intraglandular dissemination, lymphocytic and stromal tumor response, and absence of lymphocytic thyroiditis were predictive, and older age (≥45 years) and follicular variant PTC were protective for lymph node metastasis. In order to optimize the management of papillary thyroid carcinomas, pathologists should search for the clues of lymph node metastasis particularly intraglandular dissemination, lateral tubular growth, tumor border and lymphocytic/stromal tumor response, multifocality, concomitant lymphocytic thyroiditis besides the actual prognostic criteria especially in younger aged male patients.

Entities:  

Mesh:

Year:  2015        PMID: 26209182     DOI: 10.1007/s12022-015-9382-7

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  35 in total

1.  AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology.

Authors:  R H Cobin; H Gharib; D A Bergman; O H Clark; D S Cooper; G H Daniels; R A Dickey; D S Duick; J R Garber; I D Hay; J S Kukora; H M Lando; A B Schorr; M A Zeiger
Journal:  Endocr Pract       Date:  2001 May-Jun       Impact factor: 3.443

2.  Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system.

Authors:  R Michael Tuttle; Hernan Tala; Jatin Shah; Rebecca Leboeuf; Ronald Ghossein; Mithat Gonen; Matvey Brokhin; Gal Omry; James A Fagin; Ashok Shaha
Journal:  Thyroid       Date:  2010-10-29       Impact factor: 6.568

Review 3.  Regulatory T cells in ovarian cancer: biology and therapeutic potential.

Authors:  Brian Barnett; Ilona Kryczek; Pui Cheng; Weiping Zou; Tyler J Curiel
Journal:  Am J Reprod Immunol       Date:  2005-12       Impact factor: 3.886

4.  Papillary thyroid carcinomas with cervical lymph node metastases can be stratified into clinically relevant prognostic categories using oncogenic BRAF, the number of nodal metastases, and extra-nodal extension.

Authors:  Julio Ricarte-Filho; Ian Ganly; Michael Rivera; Nora Katabi; Weimin Fu; Ashok Shaha; R Michael Tuttle; James A Fagin; Ronald Ghossein
Journal:  Thyroid       Date:  2012-04-03       Impact factor: 6.568

5.  A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group.

Authors:  D P Byar; S B Green; P Dor; E D Williams; J Colon; H A van Gilse; M Mayer; R J Sylvester; M van Glabbeke
Journal:  Eur J Cancer       Date:  1979-08       Impact factor: 9.162

6.  Cervical lymph node metastasis and papillary thyroid carcinoma: does the compartment involved affect survival? Experience from the SEER database.

Authors:  Valerie A Smith; Roy B Sessions; Eric J Lentsch
Journal:  J Surg Oncol       Date:  2012-03-05       Impact factor: 3.454

Review 7.  Papillary thyroid carcinoma: an update.

Authors:  Virginia A LiVolsi
Journal:  Mod Pathol       Date:  2011-04       Impact factor: 7.842

8.  Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.

Authors:  Sophie Leboulleux; Carole Rubino; Eric Baudin; Bernard Caillou; Dana M Hartl; Jean-Michel Bidart; Jean-Paul Travagli; Martin Schlumberger
Journal:  J Clin Endocrinol Metab       Date:  2005-07-19       Impact factor: 5.958

9.  Prognostic factors of papillary and follicular carcinomas in Japan based on data of kuma hospital.

Authors:  Yasuhiro Ito; Akira Miyauchi
Journal:  J Thyroid Res       Date:  2011-09-29

10.  Prognosis of multifocal papillary thyroid carcinoma.

Authors:  Sheng-Fong Kuo; Shu-Fu Lin; Tzu-Chieh Chao; Chuen Hsueh; Kun-Ju Lin; Jen-Der Lin
Journal:  Int J Endocrinol       Date:  2013-12-30       Impact factor: 3.257

View more
  5 in total

1.  Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.

Authors:  J-W Feng; H Pan; L Wang; J Ye; Y Jiang; Z Qu
Journal:  J Endocrinol Invest       Date:  2019-11-20       Impact factor: 4.256

2.  Prediction of cervical lymph node metastasis with contrast-enhanced ultrasound and association between presence of BRAFV600E and extrathyroidal extension in papillary thyroid carcinoma.

Authors:  Jia Zhan; Long-Hui Zhang; Qing Yu; Chao-Lun Li; Yue Chen; Wen-Ping Wang; Hong Ding
Journal:  Ther Adv Med Oncol       Date:  2020-08-06       Impact factor: 8.168

3.  Relationship between lymphovascular invasion and clinicopathological features of papillary thyroid carcinoma.

Authors:  Atakan Sezer; Mehmet Celik; Buket Yilmaz Bulbul; Nuray Can; Ebru Tastekin; Semra Ayturk; Funda Ustun; Sibel Guldiken; Necdet Sut
Journal:  Bosn J Basic Med Sci       Date:  2017-05-20       Impact factor: 3.363

4.  Risk factors associated with intrathyroid extension of thyroid microcarcinomas.

Authors:  Nikola Slijepcevic; Vladan Zivaljevic; Aleksandar Diklic; Milan Jovanovic; Branislav Oluic; Ivan Paunovic
Journal:  Langenbecks Arch Surg       Date:  2018-05-17       Impact factor: 3.445

5.  Predictive Risk-scoring Model For Central Lymph Node Metastasis and Predictors of Recurrence in Papillary Thyroid Carcinoma.

Authors:  Lie-Hao Jiang; Ke-Xin Yin; Qing-Liang Wen; Chao Chen; Ming-Hua Ge; Zhuo Tan
Journal:  Sci Rep       Date:  2020-01-20       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.